X

Gufic BioSciences Ltd Q2FY24; 15% rise in Profits

Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.

Financial Results:

  • Gufic BioSciences Ltd reported Revenues for Q2FY24 of ₹215.00 Crores up from ₹175.00 Crore year on year, a rise of 22.86%.
  • Total Expenses for Q2FY24 of ₹184.00 Crores up from ₹149.00 Crores year on year, a rise of 23.49%.
  • Consolidated Net Profit of ₹23.00 Crores up 15.0% from ₹20.00 Crores in the same quarter of the previous year.
  • The Earnings per Share is ₹2.39, up 14.90% from ₹2.08 in the same quarter of the previous year.

Tags: bioscience
Related Post